On the one hand, a reduction in 5-HT1A receptor availability across different limbic and cortical regions, mesiotemporal cortex and raphe nuclei was demonstrated in various cohorts of MDD patients (including in non-remitters) [6, 8–10]. Here, HTR1A is linked to major depressive disorder.